Basic Information
Basic information for PTPRG-AS1-219-13aa-2
Peptide Name PTPRG-AS1-219-13aa-2
Genome Position chr3:62262395-62262433[-]
Species Human
Peptide Sequence MVYVNYKYLCPYP
Peptide Length 13
Unique No (PTPRG-AS1-201-13aa,PTPRG-AS1-204-13aa,PTPRG-AS1-211-13aa,PTPRG-AS1-212-13aa-2,PTPRG-AS1-213-13aa-2,PTPRG-AS1-214-13aa,PTPRG-AS1-217-13aa-1,PTPRG-AS1-218-13aa-2,PTPRG-AS1-221-13aa,PTPRG-AS1-222-13aa,PTPRG-AS1-223-13aa-2,PTPRG-AS1-226-13aa)
Grand Average of Hydropathicity 0.0615
Relative Molecular Mass 1869.17
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000241472;PTPRG-AS1
Transcript ID/Name ENST00000664758;PTPRG-AS1-219
Transcript Length 2758
Coding Ability 0.3735
DNA Sequence Corresponding to Peptide ATGGTATATGTTAACTATAAATATCTATGCCCCTACCCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :